From R&D to Market Launch: Industry Regulations and Market Trends for Food-Specific IgG Antibody Test Kits

Medical Device Registration and Classification Management

Food-specific IgG antibody detection kits are regulated in China as Class II or Class III in vitro diagnostic reagents, with the specific classification depending on whether they are intended for auxiliary diagnosis or screening. When applying for registration, it is necessary to submit product technical requirements, analytical performance evaluation data (such as precision, accuracy, linear range, interference testing, etc.), and clinical evaluation data. Clinical evaluation may be completed through clinical trials or literature analysis based on similar products. It is noteworthy that the National Medical Products Administration (NMPA) imposes strict restrictions on the wording of intended use; terms such as "definitive diagnosis" and "cure" must not appear, and neutral expressions such as "auxiliary assessment" and "indication" should be used. In addition, key components of the kit, such as antigens and enzyme-labeled antibodies, require a stable supply chain and traceable records.

Quality Control Standards and Consistency Challenges

Due to the wide variety of food antigens (commonly as many as 20–50 types), different manufacturers vary considerably in antigen extraction processes, purification levels, and coating conditions, which may lead to inconsistent test results for the same sample across different kits. The industry calls for the establishment of unified reference materials or calibrators to enhance comparability. In the production process, compliance with the Good Manufacturing Practice for Medical Devices (GMP) is a basic requirement, especially regarding the source and inter-batch variation control of quality control materials such as negative serum and positive serum. Internal control indicators should include: intra-batch coefficient of variation (CV) typically required to be ≤10%, and inter-batch CV ≤15%; sensitivity must cover different gradients from negative to strongly positive.

Market Development Trends and Compliant Promotion

The divergence between consumer-grade testing (home self-testing) and medical-grade testing is becoming increasingly evident. The former requires attention to whether it qualifies as a "self-testing" medical device, while the latter must strictly follow the procurement processes of medical institutions.

In internet platform promotion, exaggeration of indications should be avoided; terms such as "gastrointestinal discomfort" and "say goodbye to allergies" violate the Advertising Law.

Demand for food-specific IgG antibody testing at third-party clinical laboratories continues to grow, and kit suppliers need to provide more comprehensive traceability systems and quality control packages.

New technologies such as multiplex bead-based flow fluorescence immunoassay and protein microarrays are driving up testing throughput, but the corresponding registration pathways typically require longer clinical evaluation cycles.

Overall, the food-specific IgG antibody detection kit industry is in a phase of parallel standardization and technological upgrading. Companies need to balance clinical evidence and commercialization speed, winning long-term trust through rigorous scientific attitudes and compliant market strategies.